William Blair analyst Margaret Kaczor upgraded Staar Surgical to Outperform from Market Perform. The “broad-based beat” in this morning’s fiscal Q1 pre-release adds confidence to Staar’s 2024 performance, the analyst tells investors in a research note. The shares are up 15% to $45.03 in afternoon trading.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
